| 27 Apr, 08:59 am | — | … | Cohance Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on April 27, 2026. | nse |
| 13 Apr, 05:56 pm | — | … | Cohance Lifesciences Ltd - 543064 - Clarification With Respect To Volume Movement | bse |
| 13 Apr, 04:10 pm | — | … | Cohance Lifesciences Ltd - 543064 - Clarification sought from Cohance Lifesciences Ltd | bse |
| 12 Apr, 11:44 pm | — | … | Significant increase in volume has been observed in Cohance Lifesciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Cohance Lifesciences Limited has submitted their response. | nse |
| 10 Apr, 07:29 pm | — | … | Significant increase in volume has been observed in Cohance Lifesciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. | nse |
| 30 Mar, 10:11 pm | — | … | Cohance Lifesciences Limited has informed the Exchange regarding Appointment of Mr Sisir K. Mishra as Company Secretary & Compliance Officer of the company w.e.f. April 09, 2026. | nse |
| 13 Mar, 09:20 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Options to purchase securities | nse |
| 24 Feb, 05:00 pm | — | … | Cohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 20 Feb, 04:58 pm | — | … | Cohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 | bse |
| 20 Feb, 04:57 pm | — | … | Cohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 16 Feb, 04:48 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Transcript | nse |
| 16 Feb, 04:47 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 12 Feb, 09:36 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 12 Feb, 09:33 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Link of Recording | nse |
| 12 Feb, 05:32 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 12 Feb, 05:30 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Investor Presentation | nse |
| 12 Feb, 05:20 pm | — | … | Cohance Lifesciences Ltd - 543064 - Outcome Of Board Meeting | bse |
| 12 Feb, 05:10 pm | — | … | Cohance Lifesciences Ltd - 543064 - Board Meeting Outcome for Outcome Of Board Meeting | bse |
| 12 Feb, 05:07 pm | — | … | Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |
| 06 Feb, 07:53 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about additional information on USFDA announcement | nse |
| 04 Feb, 11:17 am | — | … | Cohance Lifesciences Limited has informed the Exchange about USFDA announcement. | nse |
| 02 Feb, 08:16 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | bse |
| 02 Feb, 08:15 pm | — | … | Cohance Lifesciences Limited has informed the Exchange regarding resignation of Mr Kundan Kumar Jha as Company Secretary & Compliance Officer of the Company w.e.f. close of business hours on February 04, 2026. | nse |
| 19 Jan, 11:11 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 19 Jan, 11:07 pm | — | … | Cohance Lifesciences Limited has informed the Exchange regarding Appointment of Mr. Sunil Kumar Singh, Chief Quality officer as Senior Management Personnel of the company w.e.f. January 19, 2026. | nse |
| 19 Jan, 05:31 pm | — | … | The Exchange has sought clarification from Cohance Lifesciences Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited. | nse |
| 17 Jan, 11:38 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about grant of stock options | nse |
| 29 Dec, 07:21 pm | — | … | Cohance Lifesciences Ltd - 543064 - Board Meeting Intimation for Considering The Unaudited Financial Results (Standalone And Consolidated) Of The Company, For The Quarter And Nine-Months Ending December 31, 2025 | bse |
| 15 Dec, 05:33 pm | — | … | Cohance Lifesciences Limited has informed the Exchange regarding ''Machine Readable Form of Financial Results". | nse |
| 13 Dec, 03:15 pm | — | … | Cohance Lifesciences Limited has informed the Exchange regarding 'Intimation of change in website address of the Company'. | nse |
| 05 Dec, 06:33 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about appointment of Senior Management Personnel | nse |
| 05 Dec, 06:33 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 03 Dec, 09:42 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Credit Rating | nse |
| 03 Dec, 09:41 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 03 Dec, 09:34 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about grant of stock options | nse |
| 02 Dec, 09:57 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about General Updates | nse |
| 17 Nov, 07:43 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 17 Nov, 07:40 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Transcript | nse |
| 12 Nov, 10:24 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 12 Nov, 10:20 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Link of Recording | nse |
| 12 Nov, 06:56 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 12 Nov, 06:55 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Investor Presentation | nse |
| 12 Nov, 06:41 pm | — | … | Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | nse |
| 12 Nov, 06:37 pm | — | … | Cohance Lifesciences Ltd - 543064 - Outcome Of The Meeting | bse |
| 12 Nov, 06:31 pm | — | … | Cohance Lifesciences Ltd - 543064 - Board Meeting Outcome for Outcome Of The Board Meeting | bse |
| 05 Nov, 07:56 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Schedule of the results conference call | nse |
| 01 Nov, 05:02 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 01 Nov, 04:57 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Transcript | nse |
| 28 Oct, 08:57 pm | — | … | Cohance Lifesciences Limited has informed the Exchange about Link of Recording | nse |
| 28 Oct, 08:56 pm | — | … | Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |